Interventional Cardiology
Advertisement
Dr. Amit Goyal of the CardioNerds analyzed the BHF PROTECT-TAVI trial.
The REPAIR study offers the most comprehensive real-world assessment of outcomes after mitral TEER.
The ROLLER COASTR-EPIC22 trial is the first randomized head-to-head comparison of three plaque modification techniques.
Patients between the ages of 50 and 70 years with a mechanical heart valve have better long-term survival.
Coronary Sinus Reducer Demonstrates Long-Term Efficacy in Refractory Angina: Insights from REDUCER-I
The observational REDUCER-I study aims to evaluate the real-world safety and effectiveness of the coronary sinus reducer.
Dr. Amit Goyal details a study which explored the role of coronary sinus reducer in Coronary microvascular dysfunction.
The possibility of DCBs to rescue side branches during provisional coronary bifurcation stenting is appealing.
Dr. Amit Goyal details the first-in-human study of the Magenta Elevate system.
Mayo Clinic researchers identified a new approach to treating infective endocarditis using a catheter-based method.
Results of the EARLY TAVR trial introduced a potential paradigm shift in managing asymptomatic high-gradient severe AS.
Two pivotal trials—EARLY TAVR and EVOLVED—were presented, each exploring early intervention in asymptomatic severe AS.
ECLIPSE investigated whether OA provides better outcomes than conventional balloon angioplasty in calcified coronary lesions.
An analysis of PROTECTED TAVR trial highlighted potential regional differences in the efficacy of CEP during TAVR.
Sirolimus-coated balloons are non-inferior to paclitaxel-coated balloons in patients with femoropopliteal artery disease.
Black patients are 22% more likely to die than White patients following coronary artery bypass grafting surgery.
Researchers have developed a novel blood test that can diagnose a heart attack within minutes.
A study demonstrated long-term safety and efficacy of the GORE CARDIOFORM ASD Occluder.
The RESHAPE-HF2 trial offers further insights into the transcatheter management of patients with HFrEF and FMR.
The SENIOR-RITA trial investigates the optimal management strategy for older adults with NSTEMI.
The SCOFF trial challenges the long-standing practice of fasting before cardiac catheterization procedures.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.